Granules Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Granules Pharmaceuticals

Access the complete profile.

Granules Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3701 Concorde Pkwy Chantilly, VA 20151

Note: Revenues for privately held companies are statistical evaluations.


Granules Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Granules Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Granules Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Granules Pharmaceuticals Annual Revenue and Growth Rate

Granules Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Granules Pharmaceuticals's revenues are gauged from an analysis of company filings.

Granules Pharmaceuticals's Income Statement (based on Industry Averages)

Granules Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Granules Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Granules Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Granules Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GRANULES PHARMACEUTICALS	Chantilly, VA	100
DILIGENT HEALTH SOLUTIONS	Chantilly, VA	39
ZESTRON	Manassas, VA	16
NUTRAVAIL	Chantilly, VA	14
OMEGA HEALTH SERVICES	Manassas, VA	3
INOVEX INDUSTRIES	Sterling, VA	2

Future Competition: Granules Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Granules Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)